a high-performance liquid chromatographic ( hplc ) procedure has been evaluated to establish a routine test in the clinical laboratory for measuring the profiles of estrogen and progestin receptor isoforms in human breast and endometrial tumors .
C0184661
procedure
C0220825
evaluated